Evidence map›Paper›PMID 42053375›Full record

ReviewShock (Augusta, Ga.)2026

Heat Shock Protein 90 in Sepsis-Induced Cardiomyopathy: Mechanistic Insights and Emerging Therapeutic Target.

Xiaoying Xu, Xiong Yue, Meimei Hu, Cunmin Zhou

Abstract readReview
In one paragraph

Review in Shock (Augusta, Ga.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiaoying XuThe First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
Xiong YueThe First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
Meimei HuDepartment of Clinical Laboratory, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
Cunmin ZhouDepartment of Clinical Laboratory, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.

Funding

the National Natural Science Foundation of China 82360800
6 · The paper itself

Abstract

Sepsis-induced cardiomyopathy (SIC) is a form of cardiac dysfunction triggered by sepsis, whose pathogenesis primarily involves the release of endogenous danger signal molecules. As a key molecular chaperone, heat shock protein 90 (Hsp90) plays a fundamental role in stabilizing and activating client proteins to regulate essential cellular processes. Although the broader heat shock protein family has been studied in SIC, the specific mechanisms and therapeutic potential of Hsp90 remain to be fully elucidated. Hsp90 plays a crucial role in apoptosis, oxidative stress, mitochondrial autophagy, immune defense, and myocardial fibroblast function during heart dysfunction. This review systematically summarizes the structure and regulatory mechanisms of Hsp90 in SIC. Furthermore, we discuss recent advances in Hsp90 inhibitors, which was categorized as natural product-derived inhibitors, functional inhibitors, and structural disruptors, thereby providing a theoretical foundation and prospective strategies for novel therapeutic interventions against SIC.

Indexed as

CardiomyopathiesHSP90 Heat-Shock ProteinsSepsisAnimalsHumansOxidative StressHSP90 Heat-Shock ProteinsHsp90inhibitorspathophysiologysepsis-induced cardiomyopathy

Identifiers

PMID42053375
PMCPMC13220937

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.